Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 63629-4708

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 63629-4708). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolpidem 01

Chemical structure diagram of Zolpidem tartrate, showing the molecular arrangement of the active ingredient Zolpidem tartrate in a 6.25 mg extended release oral tablet form labeled by Bryant Ranch Prepack.*

FDA Label Image

Zolpidem 02

A line graph showing zolpidem plasma concentrations (ng/mL) over time (hours) comparing 12.5 mg extended-release zolpidem tartrate tablets and 10 mg immediate-release zolpidem tartrate tablets. The graph illustrates concentration levels rising, peaking, and declining differently between the two formulations over an 8-hour period.*

FDA Label Image

Lbl636294708

Label for Zolpidem Tartrate ER 6.25 mg extended release oral tablets, packaged by Bryant Ranch Prepack. The label includes a comparison to Ambien CR 6.25 mg tablets, notes a quantity of 28 tablets, storage instructions at 20°-25°C, and a warning about possible dizziness or drowsiness. The product NDC is 63629-4708.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.